Wilshire Institute for Interventional Psychiatry

Wilshire Institute for Interventional Psychiatry in Beverly Hills, California offers Spravato (esketamine), an FDA-approved nasal spray for treatment-resistant depression used alongside oral antidepressants in a supervised clinic setting. The premier outpatient practice specializes in major depressive disorder and treatment-resistant depression, delivering interventional therapies in thoughtfully designed private treatment rooms with customizable ambiance.

Led by Dr. Oana Galicki, the clinic pairs clinical excellence with a dedicated patient advocate team that handles all insurance authorizations, claims, and financial arrangements to minimize out-of-pocket costs. Beyond Spravato, the practice offers medication management, functional health, and life coaching, treating depression, anxiety, and PTSD. Most commercial insurance accepted. The clinic serves Beverly Hills and the surrounding Los Angeles communities.